Trials / Completed
CompletedNCT05133076
Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications
A Randomized Placebo-controlled Study to Assess Safety and Preliminary Efficacy of BGP345A in Patients With Constipation Due to the Use of Opioid-based Medications for the Management of Chronic Non Cancer Pain
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- BioGaia Pharma AB · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess safety and preliminary efficacy of BGP345A in patients with constipation due to the use of opioid-based medications for the management of chronic non cancer pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Lactobacillus gasseri BGP345A | Active and placebo capsules for oral use |
| BIOLOGICAL | Placebo | Placebo |
Timeline
- Start date
- 2022-01-20
- Primary completion
- 2024-12-12
- Completion
- 2024-12-12
- First posted
- 2021-11-24
- Last updated
- 2025-06-26
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05133076. Inclusion in this directory is not an endorsement.